| Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] |
Ab00190-1.1-BT |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] |
Ab00190-8.1-BT |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] |
Ab00190-8.4-BT |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] |
Ab00190-8.4 |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] |
Ab00190-8.1 |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] |
Ab00190-1.1 |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11a [hu1124 (Efalizumab)] |
Ab00535-1.1-BT |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11a [hu1124 (Efalizumab)] |
Ab00535-10.0-BT |
Absolute Antibody |
|
VIEW DETAILS
|
| Anti-CD11a [hu1124 (Efalizumab)] |
Ab00535-10.3-BT |
Absolute Antibody |
|
VIEW DETAILS
|
